Skip to content
BidBenchmark

Contract award

LEIDOS BIOMEDICAL RESEARCH INC

DRUG PRODUCT FORMULATION DEVELOPMENT, GMP MANUFACTURE, AND LONG-TERM STABILITY STUDIES OF BITOX FOR PHASE I CLINICAL TRIALS
PIID
75N91023F00021
Award key
CONT_AWD_75N91023F00021_7529_75N91019D00024_7529
Recipient UEI
HV8BH9BPG8Y9
Parent award
CONT_IDV_75N91019D00024_7529
Source as of
—
Current award value
$1,649,7573
Obligated to date
$1,649,7572
Potential with options
$1,649,7573
Awarding agency
Department of Health and Human ServicesNational Institutes of Health
Place of performance
Frederick, Maryland
Set-aside
None
Pricing
Cost Plus Award Fee
Competition
Full and Open Competition
Period of performance
Sep 15, 2023 — Sep 14, 2026Through Sep 14, 2028 if all options are exercised
Benchmark category
Unclassified

Transaction history

Every action recorded against this award, in the order the government reported them.

ModAction dateReasonObligationValue at action
0Sep 5, 2023Initial award$1,649,757.00$1,649,757.00
P00001Sep 14, 2026M$0.00$1,649,757.00

Provenance

Which source record produced each displayed rollup figure.

FieldSourceFileRetrievedParserArtifact hash
awarding_agency_idUSAspending.gov—Sep 16, 2026usaspending_contract_csv@2026.08.2657f7c35307b
contractor_idUSAspending.gov—Sep 16, 2026usaspending_contract_csv@2026.08.2657f7c35307b
current_award_valueUSAspending.gov—Sep 16, 2026usaspending_contract_csv@2026.08.2657f7c35307b
naics_codeUSAspending.gov—Sep 16, 2026usaspending_contract_csv@2026.08.2657f7c35307b
potential_award_valueUSAspending.gov—Sep 16, 2026usaspending_contract_csv@2026.08.2657f7c35307b
psc_codeUSAspending.gov—Sep 16, 2026usaspending_contract_csv@2026.08.2657f7c35307b
total_obligatedUSAspending.gov—Sep 16, 2026usaspending_contract_csv@2026.08.2657f7c35307b

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.

  1. 1Rollup values derive from 2 transaction records parsed from USAspending.gov, retrieved Sep 16, 2026 by transform awards@2026.08.1.
  2. 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
  3. 3Current and potential award values are taken from the latest reported action, not summed across modifications.